ERDEM, N. Et Al. 2017. The Role Of Quantitative TFPI2 Metilation As A Novel Serum Diagnostic and Prognostic Marker in Hepatopanncreaticobiliary Cancers. ESMO 19th World Congress On Gastrointestinal Cancer , (Barselona, Spain).

ERDEM, N., KASAP, E., ÖRENAY BOYACIOĞLU, S., BURAN, T., GERÇEKER, E., YÜCEYAR, M. H., ... EKTİ ULUDOĞAN, B. C.(2017). The Role Of Quantitative TFPI2 Metilation As A Novel Serum Diagnostic and Prognostic Marker in Hepatopanncreaticobiliary Cancers . ESMO 19th World Congress On Gastrointestinal Cancer, Barselona, Spain

ERDEM, NESLİHAN Et Al. "The Role Of Quantitative TFPI2 Metilation As A Novel Serum Diagnostic and Prognostic Marker in Hepatopanncreaticobiliary Cancers," ESMO 19th World Congress On Gastrointestinal Cancer, Barselona, Spain, 2017

ERDEM, NESLİHAN Et Al. "The Role Of Quantitative TFPI2 Metilation As A Novel Serum Diagnostic and Prognostic Marker in Hepatopanncreaticobiliary Cancers." ESMO 19th World Congress On Gastrointestinal Cancer , Barselona, Spain, 2017

ERDEM, N. Et Al. (2017) . "The Role Of Quantitative TFPI2 Metilation As A Novel Serum Diagnostic and Prognostic Marker in Hepatopanncreaticobiliary Cancers." ESMO 19th World Congress On Gastrointestinal Cancer , Barselona, Spain.

@conferencepaper{conferencepaper, author={NESLİHAN ERDEM Et Al. }, title={The Role Of Quantitative TFPI2 Metilation As A Novel Serum Diagnostic and Prognostic Marker in Hepatopanncreaticobiliary Cancers}, congress name={ESMO 19th World Congress On Gastrointestinal Cancer}, city={Barselona}, country={Spain}, year={2017}}